Laboratorios Farmaceuticos Rovi, S.A. (OTCMKTS:LABFF) Short Interest Up 127.4% in February

Laboratorios Farmaceuticos Rovi, S.A. (OTCMKTS:LABFF) was the recipient of a significant growth in short interest in February. As of February 28th, there was short interest totalling 48,900 shares, a growth of 127.4% from the February 13th total of 21,500 shares. Based on an average daily volume of 0 shares, the days-to-cover ratio is currently ? days.

Laboratorios Farmaceuticos Rovi Stock Performance

OTCMKTS LABFF remained flat at C$65.86 on Friday. The firm has a fifty day simple moving average of C$65.86 and a 200 day simple moving average of C$77.03. Laboratorios Farmaceuticos Rovi has a twelve month low of C$65.86 and a twelve month high of C$65.86.

About Laboratorios Farmaceuticos Rovi

Laboratorios Farmaceuticos Rovi, SA engages in the research, development, manufacture, and marketing of pharmaceutical products in Spain and internationally. The company provides products for cardiology, osteoarticular/women's health, anesthesia /pain, diagnostic imaging contrast agents, central nervous system, urology, endocrinology, respiratory, and primary healthcare areas.